How this drug Remdesivir is curing COVID-19, Trump wants it approved immediately

An experimental drug has proved effective against the new coronavirus in a major study, shortening the time it takes for patients to recover by four days on average, U.S. government and company officials announced Wednesday.

Gilead Sciences’ drug, Remdesivir is the first treatment to pass such a strict test against the virus, which has killed more than 218,000 people since it emerged late last year in China. Having a treatment could have a profound effect on the global pandemic.



The study, run by the National Institutes of Health, tested Remdesivir versus usual care in 1,063 hospitalized coronavirus patients around the world. At the White House, NIH's Dr. Anthony Fauci said the drug reduced the time it takes patients to recover by 31% — 11 days on average versus 15 days for those just given usual care.

He also said there was a trend toward fewer deaths among those on Remdesivir.

President Donald Trump has therefore called on the US Food and Drug Administration to move "as quickly as they can" to approve Remdesivir as a treatment for the dreaded coronavirus.

Share On:

Facebook Twitter WhatsApp Google+ Pinterest

Copy the link below and Share with your Friends:

Download Our Official Android App on Google Playstore HERE
OR
Download from another source HERE

Subscribe to our posts and be the first to receive email updates.

About Blogindoor
Blogindoor.com Is A Top Tech Blog That Provides Free And Cheap Browsing Cheats On Mtn, Etisalat, 9mobile, Glo And Airtel, Latest Phone And PC Updates, Tweaking Guides And Tech News.